Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. IGEA Pharma N.V.
  6. News
  7. All News
    IGPH   NL0012768675

IGEA PHARMA N.V.

(IGPH)
  Report
Delayed Swiss Exchange  -  11:35:27 2023-06-08 am EDT
0.006000 CHF   +20.00%
06/01Achiko, IGEA, Talenthouse Shares Suspended from Trading on SIX Swiss Exchange
MT
06/01IGEA Pharma Seeks Deadline Extension for FY22 Annual Report Publication
MT
05/31Igea Pharma N.v. : IGEA to apply for a further extension of its disclosure obligations
EQ
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about IGEA PHARMA N.V.
06/01Achiko, IGEA, Talenthouse Shares Suspended from Trading on SIX Swiss Exchange
MT
06/01IGEA Pharma Seeks Deadline Extension for FY22 Annual Report Publication
MT
05/31Igea Pharma N.v. : IGEA to apply for a further extension of its disclosure obligations
EQ
05/31Igea Pharma N : to apply for a further extension of its disclosure obligations
PU
05/30IGEA Pharma to Divest Industrial Process Business in Refocusing Move
MT
05/29Igea Pharma N.v. : IGEA to update on strategic refocusing decisions.
EQ
05/15Igea Pharma N : to update on unaudited key figures and ongoing matters
PU
05/15Igea Pharma N.v. : IGEA to update on unaudited key figures and ongoing matters
EQ
05/01Igea Pharma N.v. : IGEA to get SIX approval to Annual Report 2022 disclosure
EQ
05/01Igea Pharma N : Minutes of the EGM of 24 April 2023 + Attendance list
PU
05/01Igea Pharma N : to get SIX approval to Annual 2022 Report disclosure
PU
04/13IGEA Pharma Receives Fine for Breach of Listing Rules
MT
03/13Igea Pharma N : Convening notice & Agenda
PU
2022Igea Pharma N : appoints new Chief Financial Officer
PU
2022Igea Pharma N : Minutes of the AGM 1 December 2022
PU
2022Igea Pharma N : announces annual General Meeting Resolutions
PU
2022IGEA Pharma's H1 Loss Shrinks Amid Lower Expenses
MT
2022Igea Pharma N.v. : Igea discloses its 2022 Half-Year Financial Report
EQ
2022IGEA Pharma N.V. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
2022Igea Pharma N.v. : Igea discloses its 2021 annual report
EQ
2022Igea Pharma N : Convening Notice and Agenda
PU
2022IGEA Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2022Igea Pharma N.v. : IGEA to get SIX approval to the semi-annual 2022 report disclosure
EQ
2022Igea Pharma N : to get SIX approval to the semi-annual 2022 report disclosure
PU
2022Swiss Exchange Regulator Investigates IGEA Pharma For Violating Reporting Rules
MT
2022Igea Pharma N.v. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
2022Igea Pharma N : to get SIX further approval to the 2021 annual report disclosure
PU
2022IGEA Pharma Suspends Trading Amid Delayed FY21 Annual Report
MT
2022Igea Pharma N.v. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
2022IGEA Pharma Close to Finalizing $6 Million Investment Deal For Cannabidiol Extraction F..
MT
2022Igea Pharma N.v. : Igea pharma has announced that lmh - an industrial holding company - ha..
EQ
2022Igea Pharma N : Notice to postpone annual general meeting IGEA Pharma N.V.
PU
2022Igea Pharma N : Note of the Board
PU
2022Igea Pharma N.v. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
2022Igea Pharma Secures $6 Million Funds To Complete Cannabidiol Extraction Facility
MT
2022Igea Pharma N.v. : Igea pharma has signed a preliminary agreement with lmh-an industrial h..
EQ
2022IGEA Pharma Gets Swiss Bourse Approval To Delay FY21 Annual Report Publication
MT
2022Igea Pharma N.v. : IGEA to get SIX approval to delay the 2021 annual report disclosure
EQ
2022Igea Pharma N : to get SIX approval to delay the 2021 annual report disclosure
PU
2022Igea Pharma N : non-executive board members resigned after completion of the first post-co..
PU
2021Igea Pharma N : GBC Research report IGEA Pharma N.V.
PU
2021Igea Pharma N : GBC AG Publishes initial equity research report with buy recommendation an..
PU
2021Igea Pharma N.v. : Gbc ag publishes initial equity research report with buy recommendation..
EQ
2021Igea Pharma N : GBC AG to start equity coverage of IGEA Pharma
PU
2021IGEA Pharma N : H1 Loss Narrows on Gains From Financial Liabilities, Sale ..
MT
2021IGEA Pharma N.V. Reports Earnings Results for First Half 2021
CI
2021Igea Pharma N.V. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021Igea Pharma N : discloses its half-2021 financials
PU
2021Igea Pharma N : has been granted the listing of the new shares from SIX Exchange Regulatio..
PU
2021Igea Pharma N : to submit the listing prospectus to the SIX following the business combina..
PU
2021Igea Pharma N : to boost revenues entering the growing cannabis market
PU
2021IGEA Pharma N : Expects Earnings, Revenue Boost On Blue Sky Natural Resour..
MT
2021IGEA Pharma N : Declares All-Equity Offer for Blue Sky Natural Resources U..
MT
2021Igea Pharma N : Minutes of the AGM 9 July 2021 + Attendance list
PU
2021Igea Pharma N : announces Annual General Meeting resolutions
PU
2021IGEA Pharma N : Launches All-Equity Offer To Buy Blue Sky Natural Resource..
MT
2021Igea Pharma N : To launch the all equity offer to blue sky natural resources ltd.
EQ
2021Igea Pharma N : Convening notice and agenda
PU
2021IGEA Pharma N : Names New Chair
MT
2021Igea Pharma N : announces changes in its board and other corporate updates
EQ
2021IGEA Pharma N.V. Announces Executive Changes
CI
2021Igea Pharma N : announces changes in its board and other corporate updates
PU
2021Igea Pharma N : disclosed its Annual Report 2020
EQ
2021Igea Pharma : Annual report
PU
2021Igea Pharma N : disclosed its Annual Report 2020
PU
2021IGEA Pharma N : Secures $12 Million Investment From Negma
MT
2021IGEA Pharma N.V. Reports Unaudited Earnings Results for the Year 2020
CI
2021Igea Pharma N : to get SIX approval to delay the 2020 annual report disclosure
EQ
2021Igea Pharma N : to get SIX approval to delay the 2020 annual report disclosure
PU
2021Igea Pharma N : announces extraordinary general meeting results
EQ
2021Igea Pharma N : announces extraordinary general meeting results
PU
2021Igea Pharma N : Minutes of the EGM 28 April 2021
PU
2021IGEA Pharma Strikes Two-Year Convertible Bond Deal With Negma
MT
2021Igea Pharma N : to secure convertible bond commitment with Negma Group
PU
2021Igea Pharma N : to secure convertible bond commitment with Negma Group
EQ
1  2Next
Upcoming event on IGEA PHARMA N.V.
06/30/23Annual General Meeting
Upcoming sector events
07/26/23LANTHEUS HOLDINGS : Q2 2023 Earnings Release (Projected)
07/27/23DIASORIN S.P.A. : Q2 2023 Earnings Release
08/02/2310X GENOMICS : Q2 2023 Earnings Release (Projected)
08/28/23SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. : Q2 2023 Earnings Release (Projected)
Sector
Healthcare
Healthcare Services
 Healthcare Equipment & Supplies
  Medical Equipment, Supplies & Distribution
   Diagnostic & Testing Substances
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
fermer